Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED

American Journal of Emergency Medicine

Volumn 23, Issue 7, 2005, Pages 842-847

  Schreck, David M ^a,b,c,e   Babin, Stephen ^d  

^a Summit Medical Group   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Emergency Medical Associates   (United States)

^d Muhlenberg Regional Medical Center   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVALBUTEROL; SALBUTAMOL;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEREOISOMERISM; TREATMENT OUTCOME;

EID: 27744454999     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2005.04.003     Document Type: Article

References (30)

1. S.D. Alvey Asthma emergency care: national guidelines summary Heart Lung 30 2001 472 474
2. National Heart Lung and Blood Institute National Heart Lung and Blood Institute Data Fact Sheet. Asthma Statistics Available at: http://www.nhlbi.nih. gov/ Accessed Aug 18, 2003
3. D.M. Mannino, D.M. Homa, and C.A. Pertowski Surveillance for asthma-United States, 1960-1995 MMWR CDC Surveill Summ 47 1998 1 27
4. D.M. Mannino, D.M. Homa, and L.J. Akinbami Surveillance for asthma-United States, 1980-1999 MMWR Surveill Summ 51 2002 1 13
5. 2- adrenergic receptors Clin Rev Allergy Immunol 14 1996 37 45
6. D. Hartley, and D. Middlemiss Absolute configuration of the optical isomers of salbutamol J Med Chem 14 1971 895 896
7. D. Baramki, J. Koester, and A.J. Anderson Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer J Allergy Clin Immunol 109 2002 449 454
8. S.H. Cho, J.Y. Hartleroad, and C.K. Oh (S)-Albuterol increases the production of histamine and IL-4 in mast cells Int Arch Allergy Immunol 124 2001 478 484
9. A.G. Templeton, I.D. Chapman, and E.R. Chilvers Effects of S-salbutamol on human isolated bronchus Pulm Pharmacol Ther 11 1998 1 6
10. S. Mitra, M. Ugur, and O. Ugur (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle Mol Pharmacol 53 1998 347 354
11. 2-selective sympathomimetics Pulm Pharmacol 7 1994 367 376
12. T. Walle, U.K. Walle, and K.R. Thornburg Stereoselective sulfation of albuterol in humans. Biosynthesis of the sulfate conjugate by HEP G2 cells Drug Metab Dispos 21 1993 76 80
13. K. Gumbhir-Shah, D.J. Kellerman, and S. DeGraw Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects Pulm Pharmacol Ther 12 1999 353 362
14. B. Schmekel, I. Rydberg, and B. Norlander Stereoselective pharmacokinetics of S-salbutamol after administration of the racemate in healthy volunteers Eur Respir J 13 1999 1230 1235
15. D.K. Agrawal, K. Ariyaranthna, and P.W. Kelbe S-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells J Allergy Clin Immunol 113 2004 503 510
16. FA's policy statement for the development of new stereoisomeric drugs Chirality 4 1992 338 340
17. H.S. Nelson, G. Bensch, and W.W. Pleskow Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma J Allergy Clin Immunol 102 1998 943 952
18. J.C. Carl, T.R. Myers, H.L. Kirchner, and C.M. Kercsmar Comparison of racemic albuterol and levalbuterol for treatment of acute asthma J Pediatr 143 2003 731 736
19. R.M. Nowak, C.L. Emerman, and K. Schaefer Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study Am J Emerg Med 22 2004 29 36
20. R.S. Pikarsky, and R.A. Acevedo Clinical and economic impact resulting from a hospital-wide conversion from racemic albuterol to levalbuterol Chest 122 4 2002 125S [abstract]
21. R.S. Pikarsky, R.A. Acevedo, and C. Roman Comparison in rates of breakthrough treatments during a conversion from racemic albuterol to levalbuterol Chest 122 4 2002 146S [abstract]
22. M.J. Asmus, and L. Hendeles Levalbuterol nebulizer solution: is it worth five times the cost of albuterol? Pharmacotherapy 20 2000 123 129
23. T. Truitt, J. Witko, and M. Halpern Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma Chest 123 2003 128 135
24. M.A. Lewis, S.S. Harris, and S.L. Campbell Improving resource utilization with new technologies Respir Care 45 2000 981
25. R.S. Pikarsky, R. Acevedo, and C. Roman Safety and efficacy of five-minute timed aerosol administration with the aeroeclipse breath actuated nebulizer: comparison of levalbuterol with racemic albuterol Respir Care 48 2003 18 [abstract]
26. D. Huse, A. McLoney, and B. Yeager Impact of levalbuterol versus racemic albuterol on outpatient asthma care charges Value in Health 4 2001 82
27. Xopenex (levalbuterol HCI) inhalation solution Physicians' desk reference 2003 Thomas PDR Montvale (NJ) 3115 3118
28. Ventolin product information Physicians' desk reference 2003 Thomas PDR Montvale (NJ) 1674 1678
29. D. Haider Levalbuterol affords superior health and cost benefit over racemic albuterol in the emergency department Respir Care 46 2001 1081
30. D.M. Schreck, C. Brotea, S. Shah, and S. Babin Emergency department comparison of racemic albuterol and levalbuterol in the treatment of acute asthma Prehosp Emerg Care 7 2003 169 [abstract]